FGF2 and esophageal squamous cell carcinoma: A study reported that AZD4547 significantly retarded tumor growth by inducing the mesenchymal–epithelial transition (EMT), reducing ESCC stem cell-like cell populations (CSCs), and inhibiting FGF2-mediated FGFR/ERK signaling [29].